HKD 0.54
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.69 Million CNY | -79.72% |
2022 | 15.19 Million CNY | 55.68% |
2021 | -4.27 Million CNY | -21.6% |
2020 | 12.45 Million CNY | 183.99% |
2019 | 4.38 Million CNY | 202.57% |
2018 | -4.27 Million CNY | 69.56% |
2017 | -13.34 Million CNY | -0.71% |
2016 | -27.41 Million CNY | -38833.33% |
2015 | -1.64 Million CNY | 100.87% |
2014 | -4.12 Million CNY | 51.47% |
2013 | -9.68 Million CNY | 64.45% |
2012 | -23.9 Million CNY | -1.84% |
2011 | -23.47 Million CNY | -403.33% |
2010 | 7.73 Million CNY | -58.91% |
2009 | 18.83 Million CNY | 120.32% |
2008 | 8.54 Million CNY | 13.27% |
2007 | 7.54 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -3.83 Million CNY | -236.11% |
2024 Q2 | -3.83 Million CNY | 0.0% |
2023 FY | - CNY | -79.72% |
2023 Q4 | -1.14 Million CNY | -315.28% |
2023 Q3 | 530 Thousand CNY | 111.19% |
2023 Q2 | -4.73 Million CNY | -288.61% |
2023 Q1 | 2.51 Million CNY | -35.8% |
2022 Q2 | -5.17 Million CNY | -225.02% |
2022 Q4 | 3.91 Million CNY | -46.0% |
2022 Q3 | 7.24 Million CNY | 239.89% |
2022 FY | - CNY | 55.68% |
2022 Q1 | 4.14 Million CNY | 120.48% |
2021 Q3 | 1.75 Million CNY | 39.13% |
2021 Q1 | 4.62 Million CNY | 361.02% |
2021 Q2 | 1.26 Million CNY | -72.73% |
2021 Q4 | -20.22 Million CNY | -1253.68% |
2021 FY | - CNY | -21.6% |
2020 FY | - CNY | 183.99% |
2020 Q1 | -1.32 Million CNY | 64.68% |
2020 Q4 | -1.77 Million CNY | -159.6% |
2020 Q3 | 2.97 Million CNY | -28.02% |
2020 Q2 | 4.12 Million CNY | 411.16% |
2019 FY | - CNY | 202.57% |
2019 Q3 | 2.18 Million CNY | 421.76% |
2019 Q2 | -680 Thousand CNY | -132.24% |
2019 Q1 | 2.1 Million CNY | 124.89% |
2019 Q4 | -3.75 Million CNY | -271.57% |
2018 FY | - CNY | 69.56% |
2018 Q4 | -8.47 Million CNY | -332.11% |
2018 Q3 | 3.65 Million CNY | 262.22% |
2018 Q2 | -2.25 Million CNY | -3415.63% |
2018 Q1 | -64 Thousand CNY | 99.64% |
2017 Q4 | -17.94 Million CNY | -3810.02% |
2017 FY | - CNY | -0.71% |
2017 Q2 | -1.56 Million CNY | -3117.31% |
2017 Q3 | -459 Thousand CNY | 70.75% |
2017 Q1 | 52 Thousand CNY | 100.29% |
2016 Q4 | -18.16 Million CNY | -14869.11% |
2016 Q1 | 1.68 Million CNY | 127.14% |
2016 Q2 | -2.2 Million CNY | -230.84% |
2016 FY | - CNY | -38833.33% |
2016 Q3 | 123 Thousand CNY | 105.59% |
2015 FY | - CNY | 100.87% |
2015 Q2 | -983 Thousand CNY | -193.98% |
2015 Q3 | 1.62 Million CNY | 265.51% |
2015 Q4 | -6.2 Million CNY | -481.19% |
2015 Q1 | 1.04 Million CNY | 107.79% |
2014 Q2 | 484 Thousand CNY | -51.41% |
2014 FY | - CNY | 51.47% |
2014 Q4 | -13.43 Million CNY | -2532.97% |
2014 Q3 | 552 Thousand CNY | 14.05% |
2014 Q1 | 996 Thousand CNY | 107.22% |
2013 Q1 | -2.91 Million CNY | 84.13% |
2013 Q4 | -13.8 Million CNY | -52.28% |
2013 FY | - CNY | 64.45% |
2013 Q2 | -4.32 Million CNY | -48.42% |
2013 Q3 | -9.06 Million CNY | -109.4% |
2012 Q2 | -5.93 Million CNY | -72.42% |
2012 Q1 | -3.44 Million CNY | 71.96% |
2012 Q3 | -572 Thousand CNY | 90.37% |
2012 Q4 | -18.37 Million CNY | -3112.24% |
2012 FY | - CNY | -1.84% |
2011 Q1 | -4.24 Million CNY | 25.28% |
2011 Q2 | -598 Thousand CNY | 85.9% |
2011 Q3 | -10.54 Million CNY | -1662.71% |
2011 Q4 | -12.28 Million CNY | -16.52% |
2011 FY | - CNY | -403.33% |
2010 FY | - CNY | -58.91% |
2010 Q4 | -5.67 Million CNY | -186.22% |
2010 Q2 | 1.34 Million CNY | -60.31% |
2010 Q3 | 6.58 Million CNY | 388.35% |
2010 Q1 | 3.39 Million CNY | 2.38% |
2009 Q1 | 4.1 Million CNY | 0.0% |
2009 FY | - CNY | 120.32% |
2009 Q2 | 5.31 Million CNY | 29.51% |
2009 Q3 | 4.77 Million CNY | -10.24% |
2009 Q4 | 3.31 Million CNY | -30.46% |
2008 FY | - CNY | 13.27% |
2007 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Anxian Yuan China Holdings Limited | 106.4 Million HKD | 98.407% |
Water Oasis Group Limited | 345.33 Million HKD | 99.509% |
Miricor Enterprises Holdings Limited | 86.61 Million HKD | 98.043% |
Perfect Medical Health Management Limited | 577.56 Million HKD | 99.707% |
Fameglow Holdings Limited | 93.66 Million HKD | 98.19% |